Evidence for magnesium sulfate as a tocolytic agent

Obstetrical and Gynecological Survey

Volumn 52, Issue 10, 1997, Pages 652-658

  Macones, George A ^a,b   Sehdev, Harish M ^a   Berlin, Michelle ^a   Morgan, Mark A ^a   Berlin, Jesse A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Blockley Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MAGNESIUM SULFATE; PLACEBO; RITODRINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TOCOLYSIS; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; FEMALE; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; RITODRINE; TOCOLYTIC AGENTS;

EID: 0030801234     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199710000-00023     Document Type: Review

References (21)

1. Taslimi MM, Sibai BH, Amon E et al. A national survey on preterm labor. Am J Obstet Gynecol 1989;160:1352.
2. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 1983;147:277.
3. Chalmers TC, Smith H, Blackburn B et al. A method for assessing the quality of a randomized control trial. Control Clin Trial 1981;2:31.
4. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177.
5. Berlin JA, Laird NM, Sacks HS et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989;8:141.
6. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121.
7. Miller JM, Keane MWD, Horger EO. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. J Reprod Med 1982;27:348.
8. Cotton DB, Strassner HT, Hill LM et al. Comparison of magnesium sulfate, terbutaline, and a placebo for inhibition of preterm labor. J Reprod Med 1984;29:92.
9. Tchilinguirian NG, Najem R, Sullivan GB et al. The use of ritodrine and magnesium sulfate in the arrest of premature labor. Int J Gynaecol Obstet 1984;22:117.
10. Beall MH, Edgar BW, Paul RH et al. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985;153:854.
11. Hollander DI, Nagey DA, Pupkin MJ. Magnesium sulfate and ritodrine hydrochloride: A randomized comparison. Am J Obstet Gynecol 1987;156:631.
12. Wilkins IA, Lynch L, Mehalek KE et al. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol 1988;159:685.
13. Cox SM, Sherman ML, Leveno KL. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990;163:767.
14. Chau AC, Gabert HA, Miller JM. A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol 1992;80:847.
15. Parsons MT, Owens CA, Spellacy WN. Themic effects of tocolytic agents: Decreased temperature with magnesium sulfate. Obstet Gynecol 1987;69:88.
16. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstet Gynecol 1993;169:97.
17. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstet Gynecol 1993;169:960.
18. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977;129:1.
19. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta adrenergic agonist ritodrine. N Engl J Med 1992;327:308.
20. King JF, Grant A, Keirse MJNC et al. Beta-mimetics in preterm labor: An overview of the randomized controlled trials. Br J Obstet Gynaecol 1988;95:211.
21. Groome LJ, Goldenberg RL, Cliver SP et al. Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. Am J Obstet Gynecol 1992;167: 873.